Arovella Therapeutics Limited (ASX:ALA)
Australia · Delayed Price · Currency is AUD 0.0650
0.00 (0.00%)
Jul 20, 2026, 4:10 PM AEST
Arovella Therapeutics Market Cap
Arovella Therapeutics has a market cap or net worth of 78.57 million as of July 21, 2026. Its market cap has decreased by -37.04% in one year.
Market Cap
78.57M
Enterprise Value
59.20M
Revenue
3.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
ChartMarket Cap Chart
Since January 24, 2002, Arovella Therapeutics's market cap has increased from 17.67M to 78.57M, an increase of 344.53%. That is a compound annual growth rate of 6.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 78.57M | -29.67% |
| Dec 31, 2025 | 111.71M | -37.97% |
| Dec 31, 2024 | 180.10M | 72.28% |
| Dec 29, 2023 | 104.54M | 574.83% |
| Dec 30, 2022 | 15.49M | -17.41% |
| Dec 31, 2021 | 18.76M | 22.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recce Pharmaceuticals | 113.80M |
| LTR Pharma | 92.71M |
| Paradigm Biopharmaceuticals | 89.33M |
| Avecho Biotechnology | 84.27M |
| Prescient Therapeutics | 76.76M |
| Immutep | 73.69M |
| Radiopharm Theranostics | 70.88M |
| Amplia Therapeutics | 69.30M |